title: [A survey on the position of France in international clinical research as assessed by pharmaceutical laboratories].
abstract: In order to evaluate the attractiveness of France for conducting international clinical trials, a survey was performed among pharmaceutical companies that are based in France or that have affiliates in France. The survey concerned international phase II and III clinical studies carried out in 2002 and 2003. Ten pharmaceutical companies representing 36% of the French market completed the survey. 134 trials were analysed in total. France recruited 8.3% of the overall number of patients recruited, and 15.0% of those recruited within Europe. France was within the overall mean with regard to the percentage of active centres (78.5% versus 79.5%) and the percentage of patients evaluable according to protocol (86.8% versus 87.3%). In contrast, France ranked within the last third of analysed countries with respect to the speed of recruitment (1.5 versus 1.9 patients/centre/month), and the number of queries per observation (16.8 versus 10.9). The analysis of the qualitative indicators of performance showed that, although the perception of pharmaceutical companies towards the quality of French medicine and administrative authorities is positive, France notably needs to improve the productivity of its clinical research in order to enhance its attractiveness for the pharmaceutical sponsors of clinical trials.
authors.affiliation: Roche, Neuilly-sur-Seine, France.
authors.forename: Soizic
authors.initials: S
authors.lastname: Courcier-Duplantier
authors.forename: Philippe
authors.initials: P
authors.lastname: Bouhours
authors.forename: Philippe
authors.initials: P
authors.lastname: Pinton
authors.forename: Claire
authors.initials: C
authors.lastname: Sibenaler
authors.forename: Catherine
authors.initials: C
authors.lastname: Lassale
mesh_terms: D002986:Clinical Trials as Topic / Q000592:standards*; D017321:Clinical Trials, Phase I as Topic / Q000592:standards; D017322:Clinical Trials, Phase II as Topic / Q000592:standards; D003625:Data Collection; D004345:Drug Industry / Q000592:standards*; D005060:Europe; D005602:France